| Dr David Curtis Ison, MD | |
|
1340 Hal Greer Blvd, Huntington, WV 25701-3804 | |
| (304) 526-2200 | |
| (304) 399-1507 |
| Full Name | Dr David Curtis Ison |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | 1340 Hal Greer Blvd, Huntington, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548502677 | NPI | - | NPPES |
| 0357253 | Medicaid | OH | |
| 7100195900 | Medicaid | KY | |
| 1548502677 | Medicaid | WV |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Virginia Regional Emergency Physicians Llc | 4183991227 | 79 |
| Cabell Huntington Hospital Inc | 3274436340 | 68 |
News Archive
The UK needs to increase its investment in science and engineering research if it is to continue to be a successful nation.
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
"Saying they are 'gravely concerned about reports that the Obama Administration's FY 2014 budget requests for PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria fail to provide adequate resources,' researchers and physicians from programs, centers and institutions leading the international AIDS response sent a letter to Secretary of State John Kerry Friday, urging him to speak up for funding that will back policy and pursue the goal of an AIDS-free generation," the Center for Global Health Policy's "Science Speaks" blog reports.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the cost of Roche/Chugai's Avastin, followed by concerns about its efficacy and side-effect profile, are cited most frequently by surveyed oncologists as the factors preventing their use of Avastin for non-small-cell lung cancer treatment in Germany, France, Italy, Spain and the United Kingdom.
Most of us remember a time when we could eat anything we wanted and not gain weight. But a new study suggests your metabolism, the rate at which you burn calories, actually peaks much earlier and starts its inevitable decline later than you might think.
› Verified 6 days ago
| Entity Name | Western Virginia Regional Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386183028 PECOS PAC ID: 4183991227 Enrollment ID: O20170522001368 |
News Archive
The UK needs to increase its investment in science and engineering research if it is to continue to be a successful nation.
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
"Saying they are 'gravely concerned about reports that the Obama Administration's FY 2014 budget requests for PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria fail to provide adequate resources,' researchers and physicians from programs, centers and institutions leading the international AIDS response sent a letter to Secretary of State John Kerry Friday, urging him to speak up for funding that will back policy and pursue the goal of an AIDS-free generation," the Center for Global Health Policy's "Science Speaks" blog reports.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the cost of Roche/Chugai's Avastin, followed by concerns about its efficacy and side-effect profile, are cited most frequently by surveyed oncologists as the factors preventing their use of Avastin for non-small-cell lung cancer treatment in Germany, France, Italy, Spain and the United Kingdom.
Most of us remember a time when we could eat anything we wanted and not gain weight. But a new study suggests your metabolism, the rate at which you burn calories, actually peaks much earlier and starts its inevitable decline later than you might think.
› Verified 6 days ago
| Entity Name | App Of Tennessee Ed Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003230236 PECOS PAC ID: 8123251766 Enrollment ID: O20180814002326 |
News Archive
The UK needs to increase its investment in science and engineering research if it is to continue to be a successful nation.
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
"Saying they are 'gravely concerned about reports that the Obama Administration's FY 2014 budget requests for PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria fail to provide adequate resources,' researchers and physicians from programs, centers and institutions leading the international AIDS response sent a letter to Secretary of State John Kerry Friday, urging him to speak up for funding that will back policy and pursue the goal of an AIDS-free generation," the Center for Global Health Policy's "Science Speaks" blog reports.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the cost of Roche/Chugai's Avastin, followed by concerns about its efficacy and side-effect profile, are cited most frequently by surveyed oncologists as the factors preventing their use of Avastin for non-small-cell lung cancer treatment in Germany, France, Italy, Spain and the United Kingdom.
Most of us remember a time when we could eat anything we wanted and not gain weight. But a new study suggests your metabolism, the rate at which you burn calories, actually peaks much earlier and starts its inevitable decline later than you might think.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Curtis Ison, MD 1340 Hal Greer Blvd, Huntington, WV 25701-3804 Ph: (304) 526-2200 | Dr David Curtis Ison, MD 1340 Hal Greer Blvd, Huntington, WV 25701-3804 Ph: (304) 526-2200 |
News Archive
The UK needs to increase its investment in science and engineering research if it is to continue to be a successful nation.
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
"Saying they are 'gravely concerned about reports that the Obama Administration's FY 2014 budget requests for PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria fail to provide adequate resources,' researchers and physicians from programs, centers and institutions leading the international AIDS response sent a letter to Secretary of State John Kerry Friday, urging him to speak up for funding that will back policy and pursue the goal of an AIDS-free generation," the Center for Global Health Policy's "Science Speaks" blog reports.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the cost of Roche/Chugai's Avastin, followed by concerns about its efficacy and side-effect profile, are cited most frequently by surveyed oncologists as the factors preventing their use of Avastin for non-small-cell lung cancer treatment in Germany, France, Italy, Spain and the United Kingdom.
Most of us remember a time when we could eat anything we wanted and not gain weight. But a new study suggests your metabolism, the rate at which you burn calories, actually peaks much earlier and starts its inevitable decline later than you might think.
› Verified 6 days ago
Leonard White, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1249 15th St, Suite 2000, Huntington, WV 25701 Phone: 304-691-1000 Fax: 304-691-1153 | |
George J Linsenmeyer Iii, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1249 15th St Ste 4000, Huntington, WV 25701 Phone: 304-691-8500 | |
Maria Gracia Luzuriaga Bassante, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1249 15th St Ste 3000, Huntington, WV 25701 Phone: 304-691-1000 | |
Dr. Everett B Wray Iii, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1249 15th Street, Suite 4000, Huntington, WV 25701 Phone: 304-691-8500 Fax: 304-691-8510 | |
Mustafa Awili, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 First Avenue, Room 1025, Huntington, WV 25702 Phone: 304-399-7484 Fax: 304-399-7579 | |
Helgi K Sigmundsson, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5170 Us Rt 60 East, Huntington, WV 25705 Phone: 304-528-4600 | |
Sara Catherine Allman, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1540 Spring Valley Dr, Huntington, WV 25704 Phone: 304-429-6741 Fax: 304-429-0362 |